ABBV has been in the news 333% more than usual
Mar 26, 2026, 8:31 AM
0.82%
What does ABBV do
AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
ABBV has been in the news recently: AbbVie is expanding its "Striking Out Cancer" campaign in partnership with MLB, pledging to donate $20 for every strikeout during the 2026 season, with a total donation cap of $1 million. Additionally, Allergan Aesthetics is leading trends in the aesthetic market with its JUVÉDERM® Collection and showcased research on TrenibotulinumtoxinE's effectiveness at the AMWC.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.